loader2
Partner With Us NRI

Shukra Pharmaceuticals Ltd share Price Today

Company details

238.50
238.50
41.76
238.50
6M Return 98.75%
1Y Return 283.13%
Mkt Cap.(Cr) 261.09
Volume 5,151
Div Yield 0.08%
OI
-
OI Chg %
-
Volume 5,151

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Shukra Pharmaceuticals Ltd shares SWOT Analysis

Strengths (15)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Company with high TTM EPS Growth
  • New 52 week high today

Weakness (0)

Data not found

Opportunity (3)

  • Positive Breakout Third Resistance ( LTP > R3)
  • Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE
  • Highest Recovery from 52 Week Low

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 238.5
R2 238.5
R3 238.5
Pivot

238.50

S1 238.5
S2 238.5
S3 238.5
EMA SMA
179.3
152.9
138.7
130.8
171.0
145.7
124.8
126.9
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
Name Category Shares
ANAR JAYESHBHAI PATEL PROMOTER 1%
DAKSHESH RAMESHCHANDRA SHAH PROMOTER 1%
SUJAY JYOTINDRA MEHTA PROMOTER 0.71%
PAYAL SUJAY MEHTA PROMOTER 0.52%
ANAR PROJECT PRIVATE LIMITED PROMOTER 18.78%
PARSHVA TEXCHEM INDIA PRIVATE LIMITED PROMOTER 17.17%
NAVKAR SURGICAL GUJARAT LIMTIED PROMOTER 11.78%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Shukra Pharmaceuticals Ltd Stocks COMPARISON

Financials( in Cr) Shukra Pharma. Sun Pharma.Inds. Cipla Dr Reddy`s Labs Divi`s Lab.
Price 238.50 1,561.25 1,466.40 6,442.15 3,648.10
% Change 5 0.21 0.90 1.23 0.07
Mcap Cr 261.09 374,596.18 118,389.80 107,460.86 96,845.75
Revenue TTM Cr 58.83 43,885.68 15,790.60 24,669.70 7,767.51
Net Profit TTM Cr 4.41 8,560.84 2,513.47 4,507.30 1,823.38
PE TTM 13.42 39.84 29.68 20.30 70.00
1 Year Return 283.13 61.19 52.35 43.90 24.91
ROCE 18.84 16.79 14.76 25.99 19.30
ROE 21.18 16.46 10.66 21.21 14.89
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 25.29 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 24,237.34 -6,671.37
LAST 3M 66,180.77 -16,581.78
LAST 6M 123,999.37 13,119.57
LAST 12M 183,206.60 175,293.18

Shukra Pharmaceuticals Ltd Information

Stock PE (TTM)
13.42
Promoter Holding
50.96%
Book Value
40.4341
ROCE
18.84%
ROE
21.18%
Description
  • Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September, 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others. The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat. The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world. In FY 2013-14, the Company got approval from Hon`ble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited (Transferor Company) with Relish Pharmaceuticals Limited (Transferee Company) and Re-organization of Share Capital of Relish Pharmaceuticals Limited (Transferee Company) through Scheme of Arrangement vide Hon`ble High Court of Gujarat order dated 20 Dec` 2013.

Registered Address

3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054

Tel : 91-079-66522247/27498515
Email : info:relishpharma.com
Website : http://www.shukrapharmeceuticals.com
Registrar

Sharepro Services

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524632
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : XT
ISIN : INE551C01028

FAQ’s on Shukra Pharmaceuticals Ltd Shares

You can buy Shukra Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Shukra Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Feb 23, 2024 04:01 PM the closing price of Shukra Pharmaceuticals Ltd was ₹ 238.50.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Feb 23, 2024 04:01 PM, the market cap of Shukra Pharmaceuticals Ltd stood at ₹ 261.09.

The latest PE ratio of Shukra Pharmaceuticals Ltd as of Feb 23, 2024 04:01 PM is 13.42

The latest PB ratio of Shukra Pharmaceuticals Ltd as of Feb 23, 2024 04:01 PM is 0.18

The 52-week high of Shukra Pharmaceuticals Ltd is ₹ 238.50 while the 52-week low is ₹ 41.76

Download Our

Download App
market app